The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.38 USD | -0.39% | +5.63% | +2.07% |
02:47pm | COVID shots for JN.1 variant neutralize newer strains, vaccine makers say | RE |
06-04 | Pfizer: article on Lyme vaccine in The Lancet | CF |
(Reuters) - Pfizer on Wednesday forecast 2024 revenue that was below Wall Street expectations, and increased its target for cost cuts by $500 million.
The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
1st Jan change | Capi. | |
---|---|---|
+2.07% | 167B | |
+42.54% | 750B | |
+34.11% | 606B | |
-6.43% | 356B | |
+18.52% | 326B | |
+6.20% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+7.53% | 165B |